Global Emphysema Treatment Market to Reach $7.4 Billion by 2029, Growing at 8% CAGR

What industry-specific factors are fueling the growth of the emphysema treatment market?
The increasing incidence of chronic obstructive pulmonary disease (COPD) is predicted to fuel the emphysema treatment market's expansion. COPD, a collection of conditions leading to airflow obstruction and breathing problems, includes emphysema and chronic bronchitis. Emphysema treatments are crucial in slowing down the progress of COPD as they concentrate on symptom management, respiratory function restoration, and disease progression delay. Reports from the Australian Institute of Health and Welfare (AIHW), an agency based in Australia, stated in June 2024 that approximately 638,000 individuals, or 2.5% of Australia's population, were diagnosed with COPD in 2022. By 2023, COPD had increased to represent 3.6% of the total disease burden, making up 50% of the overall respiratory condition burden. Additionally, in 2022, COPD was the primary reason behind 7,691 deaths, equivalent to 29.6 deaths per 100,000 people, making up 4.0% of the country's total fatalities. Hence, the uptick in COPD cases is propelling the emphysema treatment market.

Get Your Emphysema Treatment Market Report Here:
https://www.thebusinessresearchcompany.com/report/emphysema-treatment-global-market-report

What Is the projected market size and growth rate for the emphysema treatment market?
The market for emphysema treatment has experienced significant growth in recent years. The market value is expected to increase from $5.15 billion in 2024 to $5.43 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 5.6%. The surge observed in history is tied to various factors such as the effect of widespread smoking, progress in medical treatments, the implementation of pulmonary rehabilitation programs, the enhancement of diagnostic tools, as well as increased understanding and education.

The market size for emphysema treatment is projected to experience significant expansion in the coming years, reaching $7.4 billion by 2029 with a compound annual growth rate (CAGR) of 8.0%. The escalation in the forecast period is associated with factors such as the aging population, personalized treatment methods, broader availability of therapy options, emphasis on symptom control, and cooperative healthcare networks. Key trends to watch out for in this forecast period involve the investigation into gene treatments, prioritization of patient education and empowerment, the inclusion of artificial intelligence (AI), heightened access to treatment, and the progress in long-lasting medications.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10807&type=smp

What new trends are reshaping the emphysema treatment market and its opportunities?
Top firms in the emphysema market are innovating minimally invasive procedures for patients with emphysema, to strengthen their market position. These minimally invasive procedures are medical or surgical interventions that cause less disruption to the body's usual functions. For example, Adena Health System, a healthcare company based in the US, rolled out a new procedure called Zephyr Valve surgery in January 2022. This minimally invasive procedure presents another option to traditional lung volume reduction surgery for those suffering from lung hyperinflation, a common problem in emphysema and COPD. This pioneering technique places tiny Zephyr Valves in the airways of the lungs using a bronchoscope. These valves help expel trapped air, hinder further build-up, and provide room for healthier parts of the lung to expand, thereby enhancing breathing.

What major market segments define the scope and growth of the emphysema treatment market?
The emphysema treatment market covered in this report is segmented -

1) By Treatment: Smoking Cessation, Bronchodilators, Steroids, Leukotriene Modifiers, Supplemental Oxygen, Antibiotics, Gene Therapy, Surgery Transplant, Other Treatments
2) By Distribution Channel: Online Providers, Drug Stores and Retail Pharmacies, Hospital Pharmacies
3) By End-User: Clinics, Surgical Centre, Other End-Users

Subsegments:
1) By Smoking Cessation: Nicotine Replacement Therapy (NRT), Prescription Medications, Behavioral Therapy Programs
2) By Bronchodilators: Short-Acting Beta-Agonists (SABAs), Long-Acting Beta-Agonists (LABAs), Anticholinergics
3) By Steroids: Inhaled Corticosteroids (ICS), Oral Corticosteroids, Combination Inhalers
4) By Leukotriene Modifiers: Montelukast, Zafirlukast
5) By Supplemental Oxygen: Portable Oxygen Concentrators, Continuous Flow Oxygen Systems, Pulse Dose Oxygen Systems
6) By Antibiotics: Macrolides, Fluoroquinolones, Tetracyclines
7) By Gene Therapy: Gene Replacement Therapy, Antisense Oligonucleotides
8) By Surgery Transplant: Lung Volume Reduction Surgery (LVRS), Lung Transplantation
9) By Other Treatments: Pulmonary Rehabilitation Programs, Nutritional Support, Palliative Care

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10807

Which region dominates the emphysema treatment market?
North America was the largest region in the emphysema treatment market in 2024. The regions covered in the emphysema treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Which key market leaders are driving the emphysema treatment industry growth?
Major companies operating in the emphysema treatment market include AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., Novartis AG, GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Boehringer Ingelheim GmbH, Mylan N.V., Pfizer Inc., Orion Oyj, Verona Pharma PLC, Pulmonx Corporation, Emphasys Medical Inc., Halozyme Therapeutics Inc., Mariposa Health Limited, Uptake Technologies Inc., Respinova Ltd, Gala Therapeutics Inc., Pulmatrix Inc., Broncus Medical Inc., Holaira Inc., PneumRx Inc., Spiration Inc., Aeris Therapeutics Inc., CSA Medical Inc., Olympus Corporation

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=10807&type=smp

What Is Covered In The Emphysema Treatment Global Market Report?

• Market Size Forecast: Examine the emphysema treatment market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the emphysema treatment market for a structured understanding.
• Key Players Overview: Analyze major players in the emphysema treatment market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the emphysema treatment market.
• Segment Contributions: Evaluate how different segments drive overall growth in the emphysema treatment market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the emphysema treatment market.
• Industry Challenges: Identify potential risks and obstacles affecting the emphysema treatment market.
• Competitive Landscape: Review strategic developments in the emphysema treatment market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.